Nifedipine improves left ventricular function in patients with hypertension.

Area of Science:

• Cardiology
• Pharmacology
• Hypertension Research

Background:

• Essential hypertension poses significant cardiovascular risks.
• Understanding the hemodynamic effects of antihypertensive agents is crucial for patient management.
• Nifedipine gastrointestinal therapeutic system (GITS) is a sustained-release formulation of nifedipine.

Purpose of the Study:

• To evaluate the effects of nifedipine GITS on blood pressure (BP), systemic vascular resistance (SVR), and left ventricular (LV) performance in patients with essential hypertension.
• To assess the impact of both initial and long-term nifedipine GITS treatment on LV systolic and diastolic function.

Main Methods:

• Eight patients with essential hypertension were studied.
• Left ventricular (LV) systolic and diastolic performance were assessed using first-pass radionuclide cineangiography.
• Measurements were taken at rest and during upright bicycle exercise after initial and long-term BP reduction with nifedipine GITS.

Main Results:

• Initial nifedipine GITS treatment increased LV end-diastolic volume (LVEDV), stroke volume (SV), cardiac output (CO), and peak ejection rate.
• Long-term treatment led to decreased LVEDV, with SV and CO returning to baseline; early diastolic filling fraction increased, and time to peak filling rate decreased.
• Hemodynamic changes indicated an initial vasodilatory effect on LV function and a subsequent positive lusitropic effect on myocardial function with sustained use.

Conclusions:

• Nifedipine GITS is an effective antihypertensive agent.
• Hemodynamic effects include reduced SVR due to decreased vascular smooth muscle contraction.
• Long-term nifedipine GITS therapy demonstrates a direct positive lusitropic effect on myocardial function, improving diastolic performance.